Luiz R Travassos

Title: Luiz R Travassos: Innovator in Cancer Research

Introduction

Luiz R Travassos is a notable inventor based in São Paulo, Brazil. He has made significant contributions to the field of cancer research, particularly in the detection of melanoma cells. His innovative work has led to advancements in serological assays that enhance the specificity of cancer diagnostics.

Latest Patents

Travassos holds a patent for a method titled "Method for detecting the presence of G.sub.D3 ganglioside - Mouse monoclonal antibody AbR.sub.24." This patent, which has been recognized for its high degree of specificity for human melanoma cells, was published in the Proceedings of the National Academy of Sciences in 1980. The antibody AbR.sub.24 has been shown to react specifically with G.sub.D3 ganglioside, distinguishing it from other gangliosides tested. This innovation has paved the way for more accurate cancer detection methods.

Career Highlights

Travassos is affiliated with the Sloan-Kettering Institute for Cancer Research, where he has dedicated his career to advancing cancer research. His work has focused on the isolation and analysis of antigens from melanoma cells, contributing to a better understanding of cancer biology. The development of the glycolipid-mediated immune adherence (GMIA) assay is one of his notable achievements, allowing for the examination of various cells and tissues for the presence of G.sub.D3.

Collaborations

Throughout his career, Travassos has collaborated with esteemed colleagues, including Clifford S Pukel and Kenneth O Lloyd. These collaborations have further enriched his research and contributed to the advancements in cancer diagnostics.

Conclusion

Luiz R Travassos is a distinguished inventor whose work in cancer research has led to significant advancements in the detection of melanoma cells. His innovative methods and collaborations have made a lasting impact on the field, enhancing the specificity and accuracy of cancer diagnostics.